CELIA
OREJA GUEVARA
Profesora asociada de Ciencias de la Salud
University of Münster
Münster, AlemaniaPublicacions en col·laboració amb investigadors/es de University of Münster (13)
2023
-
A plain language summary of the impact of vaccines against flu and chickenpox in people with multiple sclerosis treated with cladribine tablets
Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 15-21
-
Expert opinion on COVID-19 vaccines and cladribine tablets in MS: A plain language summary
Neurodegenerative Disease Management, Vol. 13, Núm. 1, pp. 5-13
-
Expert opinion on the long-term use of cladribine tablets for multiple sclerosis: Systematic literature review of real-world evidence
Multiple Sclerosis and Related Disorders, Vol. 69
2022
-
Autoimmunity and long-term safety and efficacy of alemtuzumab for multiple sclerosis: Benefit/risk following review of trial and post-marketing data
Multiple Sclerosis Journal, Vol. 28, Núm. 5, pp. 842-846
-
Efficacy and safety of ocrelizumab in patients with relapsing-remitting multiple sclerosis with suboptimal response to prior disease-modifying therapies: A primary analysis from the phase 3b CASTING single-arm, open-label trial
European Journal of Neurology, Vol. 29, Núm. 3, pp. 790-801
-
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 28, Núm. 9, pp. 1424-1456
-
Varicella zoster virus and influenza vaccine antibody titres in patients from MAGNIFY-MS who were treated with cladribine tablets for highly active relapsing multiple sclerosis
Multiple Sclerosis Journal
2021
-
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice
Therapeutic Advances in Neurological Disorders, Vol. 14
2015
-
Comparative efficacy of switching to natalizumab in active multiple sclerosis
Annals of Clinical and Translational Neurology, Vol. 2, Núm. 4, pp. 373-387
-
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial
Neurology: Neuroimmunology and NeuroInflammation, Vol. 2, Núm. 5, pp. e147
2014
-
Clinical relevance of brain volume measures in multiple sclerosis
CNS Drugs, Vol. 28, Núm. 2, pp. 147-156
-
Specific aspects of modern life for people with multiple sclerosis: Considerations for the practitioner
Therapeutic Advances in Neurological Disorders, Vol. 7, Núm. 2, pp. 137-149
2011
-
Symptomatic therapy in multiple sclerosis: A review for a multimodal approach in clinical practice
Therapeutic Advances in Neurological Disorders, Vol. 4, Núm. 3, pp. 139-168